Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality.
TLDR
In this paper, the authors summarized the biological characteristics of Fusobacterium nucleatum and the epidemiological associations between F. nucleatum, and highlighted the mechanisms by which F.ucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment.Abstract:
Colorectal cancer (CRC) is a common cancer worldwide with complex etiology. Fusobacterium nucleatum (F. nucleatum), an oral symbiotic bacterium, has been linked with CRC in the past decade. A series of gut microbiota studies show that CRC patients carry a high abundance of F. nucleatum in the tumor tissue and fecal, and etiological studies have clarified the role of F. nucleatum as a pro-carcinogenic bacterium in various stages of CRC. In this review, we summarize the biological characteristics of F. nucleatum and the epidemiological associations between F. nucleatum and CRC, and then highlight the mechanisms by which F. nucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment (TME). We also discuss the research gap in this field and give our perspective for future studies. These findings will pave the way for manipulating gut F. nucleatum to deal with CRC in the future.read more
Citations
More filters
Journal ArticleDOI
Oral microbiota in human systematic diseases
TL;DR: In this article , the authors discussed emerging and exciting evidence of complex and important connections between the oral microbes and multiple human systemic diseases, and the possible contribution of the oral microorganisms to systemic diseases.
Journal ArticleDOI
Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer
Cheng Kong,Lei Liang,Guang Liu,Lutao Du,Yongzhi Yang,Jianqiang Liu,Debing Shi,Xinxiang Li,Yan-yan Ma +8 more
TL;DR: The predictive model based on metagenomic, metabolomic and KO gene markers achieved a powerful classification performance for distinguishing EO-CRC from controls, suggesting that altered microbiome–metabolome interplay helps explain the pathogenesis of EO.CRC.
Journal ArticleDOI
Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
TL;DR: Gut microbiota and their metabolites influence the progression and causation of CRC, and the association analysis of metabolomics and gut microbiome will provide novel strategies for the prevention, diagnosis, and therapy of CRC.
Journal ArticleDOI
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim,Helena Kupcova Skalnikova,Jana Čížková,Veronika Cizkova,A Palanová,D. Horák,Jakub Mrázek +6 more
TL;DR: In this article , the authors examined associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression.
Journal ArticleDOI
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim,Helena Kupcova Skalnikova,Jana Čížková,Veronika Cizkova,A Palanová,D. Horák,Jakub Mrázek +6 more
TL;DR: In this article , the authors examined associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression.
References
More filters
Journal ArticleDOI
Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages.
Sean P. Arlauckas,Seth B. Garren,Christopher Garris,Rainer H. Kohler,Juhyun Oh,Mikael J. Pittet,Ralph Weissleder +6 more
TL;DR: This research shows how powerful complementary single cell analytical approaches can be used to improve the understanding of drug action in vivo.
Journal ArticleDOI
Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer
Thomas N.Y. Kwong,Xiansong Wang,Geicho Nakatsu,Tai Cheong Chow,Timothy Tipoe,Rudin Z W Dai,Kelvin K.K. Tsoi,Martin C.S. Wong,Gary Tse,Matthew T. V. Chan,Francis K.L. Chan,Siew C. Ng,Justin C Y Wu,William K.K. Wu,Jun Yu,Joseph J.Y. Sung,Sunny H. Wong +16 more
TL;DR: A retrospective analysis of patients hospitalized for bacteremia associated later diagnosis of CRC with B fragilis and S gallolyticus and other intestinal microbes support a model in which specific members of the intestinal microbiota promote colorectal carcinogenesis.
Journal ArticleDOI
Role of oral microbiome on oral cancers, a review.
Pourya Gholizadeh,Hosein Eslami,Mehdi Yousefi,Mohammad Asgharzadeh,Mohammad Aghazadeh,Hossein Samadi Kafil +5 more
TL;DR: The association between the development of oral cancer in potentially malignant oral lesions with chronic periodontitis, chronic Porphyromonas gingivalis, Fusobacterium nucleatum, candida, other microbes and described mechanisms which may be involved in these carcinoma are discussed.
Journal ArticleDOI
The inflammatory pathogenesis of colorectal cancer.
TL;DR: Schmitt et al. as mentioned in this paper reviewed the current understanding of how colon cancer cells interact with their microenvironment, comprised of immune cells, stromal cells and the intestinal microbiome, to suppress or escape immune responses and how inflammatory processes shape the immune pathogenesis of CRC.
Journal ArticleDOI
Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline.
E. Gabriela Chiorean,Govind Nandakumar,Temidayo Fadelu,Sarah Temin,Ashley Efrain Alarcon-Rozas,Suyapa Bejarano,Adina-Emilia Croitoru,Surbhi Grover,Pritesh V. Lohar,Andrew Odhiambo,Se Hoon Park,Erika Ruiz Garcia,Catherine Teh,Azmina Rose,Bassem I. Zaki,Mary D. Chamberlin +15 more
TL;DR: The resource-stratified, evidence-based recommendations on the treatment and follow-up of patients with early-stage colorectal cancer are provided to complement but not replace local guidelines.